Steffen Gross, PhD Paul-Ehrlich-Institut

Steffen Gross has extensive experience in Molecular and Cell Biology.

Dr. Gross joined the Paul-Ehrlich Institute in 2005 and became Head of the Section monoclonal and polyclonal antibodies in 2012. He is involved in the assessment of the quality and preclinical issues for marketing authorization applications, scientific advice and clinical trial applications. Until 2012, Dr. Gross was laboratory head of the section monoclonal and polyclonal antibodies and involved in testing of immunoglobulins, immune sera and monoclonal antibodies as well as in planning and performing research projects. Due to his experience, he also often supports inspections as an expert for certain products.

Before joining the Paul-Ehrlich Institute, he worked in the Netherlands as well as at the National Institute of Health in Bethesda/USA.